Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.

Hunt S, Craig J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, Morrison PJ, Morrow J.

Neurology. 2006 Nov 28;67(10):1876-9.

PMID:
17130430
2.

Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers.

Mawhinney E, Craig J, Morrow J, Russell A, Smithson WH, Parsons L, Morrison PJ, Liggan B, Irwin B, Delanty N, Hunt SJ.

Neurology. 2013 Jan 22;80(4):400-5. doi: 10.1212/WNL.0b013e31827f0874. Epub 2013 Jan 9. Erratum in: Neurology. 2013 Feb 12;80(7):691.

PMID:
23303847
3.
4.

Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.

Hunt S, Russell A, Smithson WH, Parsons L, Robertson I, Waddell R, Irwin B, Morrison PJ, Morrow J, Craig J; UK Epilepsy and Pregnancy Register.

Neurology. 2008 Jul 22;71(4):272-6. doi: 10.1212/01.wnl.0000318293.28278.33.

PMID:
18645165
5.

Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.

Campbell E, Kennedy F, Russell A, Smithson WH, Parsons L, Morrison PJ, Liggan B, Irwin B, Delanty N, Hunt SJ, Craig J, Morrow J.

J Neurol Neurosurg Psychiatry. 2014 Sep;85(9):1029-34. doi: 10.1136/jnnp-2013-306318. Epub 2014 Jan 20.

PMID:
24444855
6.

Levetiracetam use and pregnancy outcome.

ten Berg K, Samrén EB, van Oppen AC, Engelsman M, Lindhout D.

Reprod Toxicol. 2005 May-Jun;20(1):175-8.

PMID:
15808801
7.

Levetiracetam monotherapy during pregnancy: a case series.

Long L.

Epilepsy Behav. 2003 Aug;4(4):447-8.

PMID:
12899868
8.

Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.

Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S.

Arch Neurol. 2011 Oct;68(10):1275-81. doi: 10.1001/archneurol.2011.133. Epub 2011 Jun 13.

PMID:
21670385
9.

Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010.

Deck GM, Nadkarni N, Montouris GD, Lovett A.

Epilepsy Behav. 2015 Oct;51:166-9. doi: 10.1016/j.yebeh.2015.07.001. Epub 2015 Aug 16.

PMID:
26283306
10.

Comparative safety of antiepileptic drugs during pregnancy.

Hernández-Díaz S, Smith CR, Shen A, Mittendorf R, Hauser WA, Yerby M, Holmes LB; North American AED Pregnancy Registry; North American AED Pregnancy Registry.

Neurology. 2012 May 22;78(21):1692-9. doi: 10.1212/WNL.0b013e3182574f39. Epub 2012 May 2.

PMID:
22551726
11.

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.

Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Sabers A, Perucca E, Vajda F; EURAP study group.

Lancet Neurol. 2011 Jul;10(7):609-17. doi: 10.1016/S1474-4422(11)70107-7. Epub 2011 Jun 5.

PMID:
21652013
12.

In utero exposure to levetiracetam vs valproate: development and language at 3 years of age.

Shallcross R, Bromley RL, Cheyne CP, García-Fiñana M, Irwin B, Morrow J, Baker GA; Liverpool and Manchester Neurodevelopment Group; UK Epilepsy and Pregnancy Register.

Neurology. 2014 Jan 21;82(3):213-21. doi: 10.1212/WNL.0000000000000030. Epub 2014 Jan 8.

PMID:
24401687
13.

Teratogenicity of the newer antiepileptic drugs--the Australian experience.

Vajda FJ, Graham J, Roten A, Lander CM, O'Brien TJ, Eadie M.

J Clin Neurosci. 2012 Jan;19(1):57-9. doi: 10.1016/j.jocn.2011.08.003. Epub 2011 Nov 21.

PMID:
22104350
14.

Antiepileptic drug use during pregnancy: perinatal outcomes.

Kulaga S, Sheehy O, Zargarzadeh AH, Moussally K, Bérard A.

Seizure. 2011 Nov;20(9):667-72. doi: 10.1016/j.seizure.2011.06.012. Epub 2011 Jul 16.

15.

Antiepileptic drug combinations not involving valproate and the risk of fetal malformations.

Vajda FJ, O'Brien TJ, Lander CM, Graham J, Eadie MJ.

Epilepsia. 2016 Jul;57(7):1048-52. doi: 10.1111/epi.13415. Epub 2016 Jun 5.

16.

Increased rate of major malformations in offspring exposed to valproate during pregnancy.

Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB; Antiepileptic Drug Pregnancy Registry.

Neurology. 2005 Mar 22;64(6):961-5.

PMID:
15781808
17.

Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.

Thomas SV, Jose M, Divakaran S, Sankara Sarma P.

Epilepsia. 2017 Feb;58(2):274-281. doi: 10.1111/epi.13632. Epub 2017 Jan 13.

19.

Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland.

Artama M, Gissler M, Malm H, Ritvanen A; Drug and Pregnancy Group.

Drug Saf. 2013 May;36(5):359-69. doi: 10.1007/s40264-013-0052-8.

PMID:
23615755
20.

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J.

J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):193-8. Epub 2005 Sep 12.

Supplemental Content

Support Center